Subscribe To

Price Alert Latest News Economic Calendar News

MKGAF / Merck KGaA (MKGAF) Q2 2023 Earnings Call Transcript

Merck KGaA (OTCPK:MKGAF) Q2 2023 Earnings Conference Call August 3, 2023 8:00 AM ET Company Participants Constantin Fest - Head of Investor Relations Belén Garijo - Chief Executive Officer Helene von Roeder - Chief Financial Officer Matthias Heinzel - Chief Executive Officer of Life Science Peter Guenter - Chief Executive Officer of Healthcare Kai Beckmann - Chief Executive Officer of Electronics Conference Call Participants Richard Foster - J.P. Morgan Matthew Weston - Credit Suisse Sachin Jain - Bank of America James Quigley - Morgan Stanley Michael Leuchten - UBS Gary Stevenson - BNP Paribas Peter Verdult - Citi Oliver Metzger - Oddo BHF Simon Baker - Redburn Dylan van Haaften - Stifel Nicolaus Rajesh Kumar - HSBC Constantin Fest Thank you very much Sharon, a very warm welcome to this Merck Q2 2023 Results Call. Read More

Demo Live Account See Partner Details

Content Topics

Merck

Kgaa

MKGAF

2023

Earnings

Call

Transcript

mkgaf

Stock

Posted: Aug 5 2023, 07:21

Author Name: Seeking Alpha

MKGAF News

By Reuters
October 30, 2023

Merck KGaA widens work on 'DNA damage' drugs in deal with China's Hengrui

Germany's Merck KGaA on Monday said it struck a collaboration deal with Chinese drugmaker Jiangsu Hengrui Pharmaceuticals to widen Merck's work in an

By Reuters
October 19, 2023

Merck KGaA says MS drug has blockbuster potential; key data expected in December

The CEO of Germany's Merck KGaA said the company's experimental multiple sclerosis drug can be a "blockbuster", an industry term for annual sales that

By Reuters
October 19, 2023

Merck KGaA raises prospect of return to sales growth next year

Germany's diversified group Merck KGaA has raised the prospect of returning to revenue growth next year, recovering from a slump in demand for its spe

By Seeking Alpha
August 13, 2023

Merck KGaA: Expect A 10% CAGR EBITDA Increase In 2024-2025

Merck KGaA reported disappointing Q2 results with a decrease in gross profit and EBIT compared to the previous year. The company remains confident in

By Seeking Alpha
August 5, 2023

Merck KGaA (MKGAF) Q2 2023 Earnings Call Transcript

Merck KGaA (OTCPK:MKGAF) Q2 2023 Earnings Conference Call August 3, 2023 8:00 AM ET Company Participants Constantin Fest - Head of Investor Relations

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.